PATENT CLAIM ANALYSIS

Application Number: 16238346
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "023000"]

Abstract:
The invention relates to novel liquid pharmaceutical compositions comprising at least one SGLT-2 inhibitor and one or more polar organic solvents, wherein the at least one SGLT-2 inhibitor comprises 1-cyano-2-(4-cyclopropyl-benzyl)-4-(β-D-glucopyranos-1-yl)-benzene according to formula (I): as well as corresponding processes of manufacturing such liquid pharmaceutical compositions and their medical uses.

Claim (Index 8):
The liquid pharmaceutical composition according to  claim 1 , wherein said liquid pharmaceutical composition additionally comprises water or an aqueous buffer.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 99.0
- Lexical Diversity: 1.34783
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15245448', '15113127', '14573352', '14672705', '15512984']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8368625328301104
- 35 USC 102 Novelty (BERT): 0.6870007364900509
- Combined Prediction Score: 0.8218763531961044
- Mean Citation Score: 464.385204
- Max Citation Score: 657.3167
- Similarity Product: 624.5311351982832

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test